Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance
Background: Real-world evidence (RWE) can reinforce clinical trial evidence in health technology assessment (HTA). Objectives: Review HTA bodies’ (HTAbs) requirements for RWE, real uses, and acceptance across seven countries (Brazil, Canada, France, Germany, Italy, Spain, and the United Kingdom) and...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2024-05-01
|
| Serija: | Journal of Market Access & Health Policy |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2001-6689/12/2/9 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
